Active filters: Briefing
Restricted
22 Apr 2024

NICE HTA process (test 22 Apr)

Teaser text: Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer malesuada dictum urna, at malesuada nulla. Aliquam tortor enim, feugiat quis metus vitae, dictum efficitur mi. Nulla scelerisque sapien nec quam ornare interdum. Curabitur mattis vestibulum consequat. Morbi ac mattis nibh. Integer et auctor leo. Donec nec aliquam arcu, at pulvinar.

Briefing
22 Feb 2024

NICE Appraisal Process (Test)

NICE, or the National Institute for Health and Care Excellence, is an executive non-departmental public body of the Department of Health in the UK. It plays a critical role in assessing pharmaceuticals to ensure they are effective and provide value for money for the NHS (National Health Service)

Briefing
Restricted
22 Feb 2024

FDA guidance on RWE (test)

Teaser text: Arma virumque cano, Troiae qui primus ab oris Italiam, fato profugus, Laviniaque venit litora, multum ille et terris iactatus et alto

Briefing
Restricted
21 Feb 2024

The process for approval of pharmaceuticals in France (test)

The Haute Autorité de Santé (HAS), or High Authority for Health in France, is responsible for the assessment and approval of pharmaceuticals. The process involves several key steps to ensure that medications are safe, effective, and offer added value to existing treatments.

Briefing
See more